BiotechTube
Home/H.U. Group Holdings/Yoshihiko Tagawa
YT

Yoshihiko Tagawa

Director, Managing Executive Officer

H.U. Group Holdings

Therapeutic Areas

OncologyNeurologyInfectious DiseaseGeneral Health Screening

H.U. Group Holdings Pipeline

DrugIndicationPhase
Blood-based p-tau/Aβ AssaysAlzheimer's Disease Diagnosis & MonitoringCommercial
Novel Cancer Biomarkers (e.g., Autoantibodies)Various Cancers (Pancreatic, Ovarian)Development & Validation
HE4 Tumor MarkerOvarian Cancer MonitoringCommercial
Infectious Disease AssaysEmerging Pathogens (e.g., SARS-CoV-2)Continuous Development
Digital Pathology & AI ToolsOncology HistopathologyDevelopment

Leadership Team at H.U. Group Holdings

MI
Mikio Ishizuka
Representative Director, President & CEO
SN
Shuji Nakamura
Director, Senior Managing Executive Officer
HO
Hiroshi Ozeki
Director, Senior Managing Executive Officer
KO
Kunio Ohyama
Director
View full H.U. Group Holdings profile